ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-05-23 7:32:07 PM | Chg. +0.90 | Volume | Bid7:59:50 PM | Ask7:59:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
145.95EUR | +0.62% | 0 Turnover: 0.00 |
145.30Bid Size: 60 | 146.45Ask Size: 60 | 226.35 bill.EUR | - | - |
GlobeNewswire
2:00 PM
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...